Serena Williams Promotes GLP-1 Weight Loss Drug in 2026 Super Bowl Advertisement

Tennis legend Serena Williams promoted GLP-1 weight loss medication in a 2026 Super Bowl ad for telehealth company Ro, sharing her personal journey of losing about 15 kg after her second pregnancy. She highlighted health benefits like lower cholesterol and reduced knee stress. The campaign, featuring injectable and pill forms, sparked debate online, with supporters noting her health improvements and critics questioning the ethics of marketing such drugs during a major event, especially given her husband's investment in Ro.